• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 3825
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Code Available (3191)
Event Date 11/30/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that a catheter and balloon had separated.A percutaneous coronary intervention was being performed and while pulling back on the 2.00mm x 12.00mm agent drug coated balloon catheter after dilation, the catheter and the balloon detached from one another and the balloon was stuck in the calcified lesion.Evacuation of the balloon was attempted by using another wire and distally placed balloon, however this attempt failed.The patient was sent to surgery for successful extraction of the balloon.The procedure was rescheduled for a later date.
 
Event Description
It was reported that a catheter and balloon had separated.A percutaneous coronary intervention was being performed and while pulling back on the 2.00mm x 12.00mm agent drug coated balloon catheter after dilation, the catheter and the balloon detached from one another and the balloon was stuck in the calcified lesion.Evacuation of the balloon was attempted by using another wire and distally placed balloon, however this attempt failed.The patient was sent to surgery for successful extraction of the balloon.The procedure was rescheduled for a later date.It was further reported the balloon and the shaft were inside patient and were removed during operation by the chirurg (surgeon).
 
Manufacturer Narrative
Device is a combination product.Age at time of event: 18 years or older.Device evaluated by mfr: returned product consisted of an agent drug coated balloon.The tip, balloon and distal shaft was not returned for analysis.The device was bloody in the hub and the shaft.Microscopic and visual inspection of the device consisted of checking the device for damage along the shaft, hypotube and hub of the device.The hypotube was had kinks located 9.5 cm and 101 cm from the strain relief, and the shaft was completely separated and damaged (stretched) 108 cm from the hub.Inspection of the remainder of the device found no damage or irregularities.The reported separation/detachment was confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8176339
MDR Text Key130910025
Report Number2134265-2018-64269
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/15/2020
Device Model Number3825
Device Catalogue Number3825
Device Lot Number2546H18
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/07/2019
Initial Date Manufacturer Received 12/03/2018
Initial Date FDA Received12/18/2018
Supplement Dates Manufacturer Received01/20/2019
Supplement Dates FDA Received02/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-